Hepatocyte nuclear DNA

Hepatocyte nuclear DNA refers to the genetic material contained within the nucleus of liver cells, serving as a critical substrate for both therapeutic intervention and toxicological damage. In the context of chronic Hepatitis B virus (HBV) infection, the persistence of viral covalently closed circular DNA (cccDNA) within the hepatocyte nucleus is a primary target for curative therapies, as it acts as the stable template for viral replication (Nassal, 2015, Gut). Modern gene-editing technologies, such as the CRISPR/Cas9 system used in NTLA-2001, specifically target sequences within the hepatocyte genome to treat systemic diseases like transthyretin amyloidosis by knocking out the TTR gene (Gillmore et al., 2021, NEJM). However, hepatocyte nuclear DNA is also a major site for drug-induced genotoxicity, where reactive metabolites can form DNA adducts that lead to mutations and hepatocellular carcinoma (Poirier, 2004, Nature Reviews Cancer). Because it encompasses the entire host genome and various viral elements, it is considered a broad therapeutic substrate rather than a specific molecular target like a protein or receptor. Monitoring DNA integrity through biomarkers such as DNA adducts or oxidative damage markers is essential for assessing the safety and efficacy of liver-targeted drugs.

Other names

Genomic DNAHepatocyte genomeNuclear DNAcccDNA (Hepatitis B virus)

Gene editing, DNA alkylation, and intercalation